Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis

Autor: R J van de Stadt, I E van der Horst-Bruinsma, M M J Nielen, A R van der Horst, Dörte Hamann, L. A. Aarden, D. van Schaardenburg, B A C Dijkmans
Přispěvatelé: Clinical Immunology and Rheumatology, AII - Amsterdam institute for Infection and Immunity, General Internal Medicine, Landsteiner Laboratory, VU University medical center
Jazyk: angličtina
Rok vydání: 2005
Předmět:
Zdroj: Annals of the rheumatic diseases, 64(8), 1199-1204. BMJ Publishing Group
Annals of the Rheumatic Diseases, 64(8), 1199-1204. BMJ Publishing Group
Nielen, MM, van der Horst, A R, van Schaardenburg, D, van der Horst-Bruinsma, I E, van de Stadt, RJ, Aarden, L A, Dijkmans, B A C & Hamann, D 2005, ' Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis ', Annals of the Rheumatic Diseases, vol. 64, no. 8, pp. 1199-1204 . https://doi.org/10.1136/ard.2004.029389
ISSN: 0003-4967
DOI: 10.1136/ard.2004.029389
Popis: Background: The anti-cyclic citrullinated peptide (CCP) test has a high sensitivity and specificity for rheumatoid arthritis, although CCP is not the physiological target of the autoantibodies. Citrullinated fibrin is abundant in inflamed synovium Objective: To assess the diagnostic and prognostic value of antibodies against citrullinated fibrinogen (ACF), a soluble precursor of fibrin, in comparison with IgM-rheumatoid factor (IgM-RF) and the second generation anti-CCP test. Methods: In 379 patients with early arthritis (258 rheumatoid and 121 undifferentiated), the sensitivity, specificity, and positive predictive value of ACF, anti-CCP, and IgM-RF for diagnosing rheumatoid arthritis were calculated. Multivariate logistic regression analysis was used to assess the diagnostic and prognostic value (radiographic progression after two years) of the tests. Results: The sensitivities of the ACF, anti-CCP, and IgM-RF tests were 55.8%, 57.8%, and 44.6%, with specificities of 92.6%, 94.2%, and 96.7%, respectively. Approximately 30% of the IgM-RF negative patients were positive for ACF or anti-CCP or both. The ACF and anti-CCP test had a high agreement in early arthritis (κ = 0.84). Of all baseline characteristics, the ACF test and the anti-CCP test were the best predictors for diagnosing rheumatoid arthritis at one year (odds ratio (OR) = 10.3 and 10.6, respectively) and for radiographic progression after two years (OR = 12.1 and 14.8). Conclusions: ACF is as sensitive as anti-CCP and more sensitive than IgM-RF in diagnosing rheumatoid arthritis in early arthritis. The ACF test is also a good predictor of radiographic progression, with a performance similar to the anti-CCP test. The ACF test and the anti-CCP test are especially valuable in IgM-RF negative arthritis.
Databáze: OpenAIRE